LAGHI PASINI, FRANCO
 Distribuzione geografica
Continente #
NA - Nord America 13.950
EU - Europa 10.468
AS - Asia 5.576
SA - Sud America 936
AF - Africa 260
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 13
AN - Antartide 1
Totale 31.224
Nazione #
US - Stati Uniti d'America 13.780
GB - Regno Unito 2.497
CN - Cina 2.104
RU - Federazione Russa 1.958
SG - Singapore 1.680
IE - Irlanda 1.390
IT - Italia 855
SE - Svezia 847
UA - Ucraina 822
BR - Brasile 791
DE - Germania 745
FR - Francia 599
VN - Vietnam 523
FI - Finlandia 412
HK - Hong Kong 405
KR - Corea 237
IN - India 152
ZA - Sudafrica 105
BD - Bangladesh 104
CA - Canada 103
ES - Italia 70
TR - Turchia 68
NL - Olanda 59
AR - Argentina 43
IQ - Iraq 43
BE - Belgio 42
JP - Giappone 40
PL - Polonia 40
CI - Costa d'Avorio 38
MX - Messico 38
NG - Nigeria 36
EC - Ecuador 28
PK - Pakistan 27
MA - Marocco 25
CZ - Repubblica Ceca 23
AT - Austria 22
TH - Thailandia 22
VE - Venezuela 19
UZ - Uzbekistan 17
AU - Australia 16
ID - Indonesia 15
CO - Colombia 14
LT - Lituania 13
SA - Arabia Saudita 13
EG - Egitto 12
GR - Grecia 12
KZ - Kazakistan 12
PH - Filippine 12
EU - Europa 11
JO - Giordania 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
CL - Cile 10
IL - Israele 10
KE - Kenya 10
NP - Nepal 9
PE - Perù 9
DZ - Algeria 8
IR - Iran 8
JM - Giamaica 8
BO - Bolivia 7
MY - Malesia 7
OM - Oman 7
RO - Romania 7
BG - Bulgaria 6
ET - Etiopia 6
HR - Croazia 6
LV - Lettonia 6
UY - Uruguay 6
HU - Ungheria 5
PY - Paraguay 5
AL - Albania 4
BB - Barbados 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
RS - Serbia 4
BH - Bahrain 3
CR - Costa Rica 3
CY - Cipro 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BN - Brunei Darussalam 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
GY - Guiana 2
HN - Honduras 2
LB - Libano 2
LK - Sri Lanka 2
QA - Qatar 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TG - Togo 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 31.198
Città #
Southend 2.233
Fairfield 1.488
Dallas 1.427
Dublin 1.361
Ashburn 1.152
Singapore 934
Chandler 734
Woodbridge 691
Jacksonville 646
Santa Clara 587
Wilmington 574
Moscow 546
Menlo Park 539
Seattle 539
Houston 535
Beijing 533
San Jose 476
Cambridge 470
Ann Arbor 397
Hong Kong 392
Siena 319
Hefei 282
Princeton 266
Helsinki 239
Nanjing 232
Seoul 232
The Dalles 195
New York 188
Los Angeles 166
Ho Chi Minh City 141
Lauterbourg 135
Boardman 118
Dearborn 113
Dong Ket 111
Hanoi 110
Munich 110
Buffalo 99
Johannesburg 97
San Diego 97
Council Bluffs 95
San Mateo 93
Nanchang 85
São Paulo 71
Shanghai 62
Florence 60
Shenyang 60
Milan 58
Columbus 49
Orem 48
Málaga 46
Tianjin 44
Brussels 40
Düsseldorf 40
Hebei 40
Turku 39
Venezia 39
Abidjan 38
Changsha 37
Kunming 37
San Francisco 36
Chicago 35
Brooklyn 34
London 34
Abuja 33
Redondo Beach 33
Toronto 33
Jiaxing 32
Montreal 32
Warsaw 32
Lancaster 30
Tokyo 30
Bengaluru 28
Jinan 28
Guangzhou 27
Frankfurt am Main 26
Izmir 26
Chennai 25
Norwalk 24
Phoenix 24
Rio de Janeiro 24
Rome 23
Amsterdam 22
Atlanta 22
Da Nang 22
Mumbai 22
Ankara 21
Falls Church 21
Washington 21
Zhengzhou 21
Lappeenranta 20
Poggiomarino 20
Belo Horizonte 19
Denver 19
Boston 18
Nuremberg 18
Haiphong 16
Mestre 16
Redwood City 16
Ningbo 15
Stockholm 15
Totale 21.598
Nome #
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 420
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 409
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 396
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation 390
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 385
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 358
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 344
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 335
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 330
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 316
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 313
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 311
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 310
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 308
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 299
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 296
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 291
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 286
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 284
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 284
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 280
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 276
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 264
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 264
Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats 259
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 257
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 257
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 252
Torsades de Pointes in patients with polymyalgia rheumatica 249
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 245
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 244
Alteration in the redox state of plasma in heart transplanted patients with moderate hyperhomocisteinemia 243
QTc interval prolongation during infusion with dipyridamole or adenosine 242
The role of P2X7 receptors in tissue fibrosis: a brief review 241
Effects of fluoxetine treatment on carbohydrate metabolism in human blood platelets: a 1H-NMR study 240
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 239
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases 238
A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly. 238
Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. 235
Heart failure and chronic kidney disease in a registry of internal medicine wards 233
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 233
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 233
Human rheumatoid synoviocytes express functional P2X7 receptors 230
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 230
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 230
Statins and the joint: multiple targets for a global protection? 227
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 225
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 224
Cytokine production from peripheral mononuclear cells in 2 patients affected by adrenomyeloneuropathy 223
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 222
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 221
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 219
Le indicazioni al trattamento con immunoglobuline endovena nelle malattie reumatiche. [Indications for intra-venous immunoglobulin treatment in rheumatic diseases] 219
Connective tissue diseases and cardiac rhythm disorders: an overview 217
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders 215
Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus 214
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 212
Simvastatin impairs humoral and cell-mediated immunity in mice by inhibiting lymphocyte homing, T-cell activation and antigen cross-presentation. 212
Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases. 211
T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives 209
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 208
Adenosine A2(A) receptor gene polymorphism (1976C > T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy 206
Modulation of P2X7 receptor during inflammation in multiple sclerosis 206
Severe acute graft versus host disease after lung transplant: report of a case successfully treated with high dose corticosteroids 204
Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease 204
Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series 202
Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. 201
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 200
Systemic adenosine increase during cold pressor test is dependent on sympathetic activation 199
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 199
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 199
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 197
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 197
Pathogenesis of the novel autoimmune-associated long-QT syndrome 197
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 196
Effect ofthymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients. -I) In vitro study. arthritis patients. -I) In vitro study 193
Pharmacokinetics and pharmacodynamics of neutrophil-associated ciprofloxacin in humans 192
Haemodynamics, rheology and mechanism of action of iloprost in man 191
Diurnal rhythm of the anticoagulant effect of continuous i.v. infusion of unfractioned heparin: a possible role for platelet activation 190
Variazioni diurne dell’ effetto anticoagulante dell’ eparina non frazionata in corso di infusione continua e.v. nell’ uomo. Modificazioni indotte da acido acetlsalicico per os 189
Using peripheral blood mononuclear cells to determine proteome profiles in human cardiac failure 188
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 188
Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates 187
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 187
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 187
Evidence of an adenosine-dependent mechanism in the hypotensive effect of L-arginine in man 186
Elevated Interleukin-6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans 186
Effects ofthymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoidarthritis patients.-II) In vivo study 185
Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature 184
Familial Mediterranean fever diagnosed in an elderly patient 182
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts 182
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 181
Peripheral neuropathy associated with ischemic vascular disease of the lower limbs 180
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 177
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture 177
ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family 176
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 176
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 173
Photopheresis immunomodulation after heart transplantation. 173
Blunted increase in plasma adenosine levels following dipyridamole stress test in dilated cardiomyopathy patients 172
Totale 23.684
Categoria #
all - tutte 95.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021242 0 0 0 0 0 0 0 0 0 0 0 242
2021/20222.075 147 273 129 173 135 58 103 105 113 180 206 453
2022/20232.706 168 243 394 385 245 546 70 191 289 64 61 50
2023/20242.205 98 31 168 103 103 632 720 57 22 51 55 165
2024/20253.944 74 207 350 248 514 238 131 216 317 175 449 1.025
2025/20269.120 763 1.369 940 1.063 1.890 394 1.134 254 331 484 333 165
Totale 31.499